Lawrence Waldman Apyx Medical Corp (APYX) insider trading activity

Lawrence Waldman is Director of Apyx Medical Corp. Currently has a direct ownership of 37,563 shares of APYX, which is worth approximately $61,603. The most recent transaction as insider was on Jul 11, 2022, when has been sold 24,000 shares (Common Stock) at a price of $2.54 per share, resulting in proceeds of $60,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.6K

0% 3M change

0% 12M change

Total Value Held $61,603

Lawrence Waldman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 11 2022	BUY Exercise of conversion of derivative security	$60,960 $2.54 p/Share	24,000 Added 38.98%	37,563 Common Stock
May 19 2022	BUY Exercise of conversion of derivative security	$22,320 $2.79 p/Share	8,000 Added 37.1%	13,563 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	$15,632 $2.81 p/Share	5,563 Added 50.0%	5,563 Common Stock

Also insider at

CMTL

COMTECH TELECOMMUNICATIONS CORP Technology

Director

CVV

CVD EQUIPMENT CORP Industrials

Director